Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Clearasil
Slough, United Kingdom
- Ownership
- Private
- Development stage
- Other
01
Overview
Clearasil is a leading global brand specializing in over-the-counter skin care and acne treatment products. Founded in 1950, the brand was the first to focus specifically on the dermatological needs of younger consumers. Its product portfolio includes a variety of medicated washes, pads, and creams that utilize active ingredients like benzoyl peroxide and salicylic acid. Currently owned by Reckitt, Clearasil remains a dominant player in the acne treatment market, distributed in numerous countries worldwide. The brand is recognized for its innovation in rapid-action formulas designed to reduce blemish size and redness quickly.
- Therapeutic areas
- Dermatology
- Modalities
- Small molecule
- Industry
- Biotech
Beyond the preview
Go deeper on Clearasil.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Clearasil.